Antidiabetic potential of algal polysaccharides: In vitro and in vivo evidence and molecular and cellular mechanisms
Year: 2026
Type: article
Abstract: Algal polysaccharides are promising antidiabetic agents due to their structural diversity and ability to modulate multiple metabolic pathways. This review summarizes in vitro and in vivo evidence on polysaccharides from brown, red, and green seaweeds, emphasizing their structural characteristics and mechanisms. They regulate carbohydrate digestion and glucose absorption by inhibiting α-amylase and α-glucosidase and modulating viscosity, substrate accessibility, and intestinal glucose transport. Systemically, they may improve insulin sensitivity and glucose utilization through IRS-1/PI3K/Akt signaling and regulate hepatic glucose and lipid metabolism through AMPK-, PPARγ-, ACC-, SREBP-1C-, and CYP7A1-related pathways. Antioxidant, anti-inflammatory, and gut microbiota-modulating effects may further contribute to metabolic benefits. Their activity is influenced by molecular weight, sulfation, monosaccharide composition, uronic acid content, glycosidic linkages, branching, and conformation. However, structural heterogeneity, inconsistent experimental approaches, limited clinical evidence, and poorly understood gastrointestinal stability remain major challenges requiring integrated structural, mechanistic, clinical, and safety investigations.
Source: Journal of Functional Foods
Language: English
Subfield: Aquatic Science
Domain: Life Sciences
Keywords: algal polysaccharides, antidiabetic drugs, seaweed, brown algae, red algae, green algae, α-amylase inhibition, α-glucosidase inhibition, glucose absorption, insulin sensitivity, hepatic glucose metabolism, hepatic lipid metabolism, AMPK signaling, PPARγ, gut microbiota, antioxidant activity, anti-inflammatory activity, polysaccharide structure-activity relationship, uronic acid, sulfation, molecular weight, gastrointestinal stability
Open Access status: gold
Estimated APC paid: $2,800
OpenAlex ID: W7230846279
